학술논문
1767MO External validation of a digital pathology-based multimodal artificial intelligence (MMAI)-derived model in high-risk localized (M0)/metastatic (M1) prostate cancer (PCa) starting androgen deprivation therapy (ADT) in the docetaxel (Doc) or abiraterone (AAP) phase III STAMPEDE trials
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S956-S956
Subject
Language
ISSN
0923-7534